Ayurveda (panchakarma, rasayana, marma, rasa shastra)

1. Introduction

Version followed: Ayurveda as India's statutory regulator (National Commission for Indian System of Medicine, NCISM, under the Ministry of Ayush), Ayurvedic teaching institutions and consumer-safety regulators (US CDC, California Department of Public Health, UK MHRA, Australia's TGA via Victoria's Better Health Channel) describe it; the psychotherapist's role is written as culturally responsive work alongside the system, not as Ayurvedic practice.

What it is. Ayurveda is a codified traditional medical system native to India, with its own colleges, degrees, statutory registers and pharmacopoeial industry. Clinical summaries describe its core theory this way: illness arises from imbalance of the body's life force (prana), and health is kept by balancing three bodily principles, the doshas (vata, pitta, kapha); each person has a unique combination, usually with one dominant dosha [source: Merck Manual, Singla 2025; Better Health Channel]. Related constitutional and digestive concepts (prakriti, constitution; agni, digestive fire; ama, undigested residue) are central in Ayurvedic textbooks [uncertain]. The term agni (digestive fire) appears in Ayurvedic clinical research [source: Kadus & Vedpathak 2017].

Therapies, as sources describe them. Practitioners take a history of symptoms, behaviour and lifestyle, observe eyes, tongue and skin, take the pulse and examine urine and stool, then individualise treatment: diet, herbal medicines, massage, meditation, yoga, and internal cleansing such as enemas and nasal rinsing [source: Merck Manual]. Panchakarma is described as a specialised set of five cleansing therapies, including induced vomiting (emesis), enemas and blood-letting, intended to detoxify and rebalance the doshas; rasa shastra medicines combine herbs with metals, minerals or gems [source: Better Health Channel]. Rasayana (rejuvenation therapy) and marma (vital points worked on through touch) are named branches of practice [uncertain]. Oil massage (abhyanga) and medicated liquids or pastes applied to the head appear among Ayurvedic procedures for mental disorders [source: KLE hospital article].

Mental health within Ayurveda (attributed). Ayurvedic institutions describe disorders of the mind (manasa roga), including anxiety, depression and psychosomatic disorders, treated by three kinds of therapy: daivavyapashraya (spiritual or divine therapy, e.g. mantras, amulets, gems, rites, fasting), yuktivyapashraya (rational therapy: diet, medicines, purification and procedures) and sattvavajaya (described as Ayurveda's psychological therapy: restraining the mind from unwholesome objects, reassurance, behavioural and occupational measures) [source: KLE hospital article; Belaguli & Savitha 2019]. Sattvavajaya is attributed by Ayurvedic scholars to the classical author Charaka [source: Belaguli & Savitha 2019]. The classical disease categories unmada (broadly, madness or insanity) and apasmara (broadly, epilepsy-like seizure disorder) are commonly cited in Ayurvedic psychiatry [uncertain]. These are the system's own concepts; this guide neither endorses nor dismisses them.

Who holds authority. In India, NCISM, the National Commission for Indian System of Medicine, was created to replace the framework of the Indian Medicine Central Council Act, 1970; it sets standards for education and practitioners of Ayurveda, Unani, Siddha and Sowa-Rigpa through autonomous boards, among them the Board of Ayurveda and the Board of Ethics and Registration for Indian System of Medicine, and only practitioners on the National Register may practise [source: PRS Legislative Research, NCISM Bill 2019 summary; NCISM website; BIMSTEC 2023 report p.47]. The year it replaced the Central Council of Indian Medicine (2021) and its place under the Ministry of Ayush are [uncertain]. Under section 33(1) of the NCISM Act 2020 a person with a recognised qualification who passes the National Exit Test is licensed and entered first in a State Register and then the National Register; those already on the earlier Central Register are deemed registered [source: BIMSTEC 2023 report p.47]. The undergraduate Ayurveda degree is the BAMS (Bachelor of Ayurvedic Medicine and Surgery), which NCISM regulates [source: NCISM website, regulation titles]. Nepal and Sri Lanka have their own government Ayurveda departments and councils [uncertain]. In the US, Ayurveda has no state licence of its own: state laws against unlicensed medical practice limit what Ayurvedic professionals may offer, some states have health-freedom laws, and the National Ayurvedic Medical Association (NAMA) sets voluntary professional standards at three levels (Ayurvedic Health Counselor, Ayurvedic Practitioner, Ayurvedic Doctor, the last not permitted to diagnose Western diseases) and works towards state licensing [source: NAMA, Being an Ayurvedic Doctor in the United States (2017)]. In the UK, Ayurvedic practitioners are not statutorily regulated, and the MHRA warns that many Ayurvedic products sold online are unlicensed and unassessed [source: MHRA notice via Bromley Council] [uncertain: statutory status]. In Australia, legal medicines carry an AUST L or AUST R number on the Australian Register of Therapeutic Goods; products without one are not TGA-registered [source: Better Health Channel; The Conversation].

Evidence status. Ayurveda has been studied for allergic rhinitis, mental health disorders, neurological conditions, pain, arthritis and diabetes, and high-quality research on whole systems is hard to conduct [source: Merck Manual]. No independent review establishing efficacy for any mental disorder is cited here. Practitioners claim to treat anxiety and stress among other conditions; these are practitioners' claims, not established results [source: Better Health Channel]. No Ayurvedic practice is presented here as a treatment for cancer or other physical disease.

How change happens, for the psychotherapist. The psychotherapist does not practise Ayurveda. Change in this work comes from understanding the client's Ayurvedic explanatory model, keeping their use of Ayurveda visible and safe (especially toxic-metal, pregnancy and purgation risks), coordinating with prescribers and registered practitioners, and preventing delay of effective care [synthesis].

2. Framework

This is not a phased protocol; it is a set of tasks that run alongside whatever psychotherapy is being delivered [synthesis].

Phase A, Engagement and cultural assessment (sessions 1–3, within intake). Goal: learn what Ayurveda means to the client, whether and how they use it, and their explanatory model. Format: Cultural Formulation Interview (CFI) core questions, supplementary modules as needed, plus a structured product-and-procedure inventory. Move on when the client's model, current Ayurvedic use and any risk flags are documented [synthesis; CFI structure: source: https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/DSM-5-TR/APA-DSM5TR-CulturalFormulationInterview.pdf].
Phase B, Safety screen and medical routing (as soon as any risk flag appears, often session 1–2). Goal: identify toxic-metal exposure risk (rasa shastra, unregistered, imported or online products, symptoms), pregnancy, fertility treatment, children in the household, eating-disorder or medical risks with purgation-based procedures, and any delay of urgent psychiatric or medical care. Route to the physician or poison control without advising on medicines. Move on once the medical team is aware and the client has agreed a plan [source: CDPH clinician guidance; MMWR 2004; synthesis for sequencing].
Phase C, Collaborative care (ongoing). Goal: with consent, coordinate with the client's registered Ayurvedic practitioner and prescriber; integrate Ayurvedic self-care the client values (diet routines, yoga, meditation) into the treatment plan where safe. Reviewed every 4–6 sessions or when the Ayurvedic regimen changes [synthesis].
Phase D, Integration and review (ongoing / ending). Goal: help the client make sense of Ayurvedic experiences, including any harm, within their identity, family and community; plan relapse prevention that respects both systems [synthesis].

Typical format: individual sessions, family sessions where products come through relatives, with an interpreter or cultural broker when needed [synthesis].

3. Guiding principles

Alongside, not instead of. The therapist does not diagnose doshas, recommend products or procedures, or deliver panchakarma, marma or sattvavajaya as Ayurveda. Practical meaning: refer Ayurvedic questions to a registered practitioner [synthesis].
Attribute, do not adjudicate. Describe doshas, manas, unmada and divine therapy as the client and the system hold them. Practical meaning: "in Ayurveda this is understood as…", not "this is true/false" [synthesis].
Ask everyone, without judgement. Regulators advise clinicians to ask all patients about herbal and Ayurvedic products from any source [source: CDPH]. Practical meaning: routine question at intake and review.
No safe level of lead. No known blood lead level is safe; low-level exposure may be silent [source: CDPH]. Practical meaning: absence of symptoms never ends the conversation.
Never advise on medicines. Do not suggest starting, stopping or changing any medicine, herbal or conventional; regulators tell consumers never to stop conventional medicine without the doctor's knowledge [source: Better Health Channel]. Practical meaning: route every medicine question to the prescriber.
Pregnancy, fertility and children first. Fetuses and young children carry added risk, notably from fertility remedies and infant tonics [source: MMWR 2004; CDPH]. Practical meaning: these flags trigger same-week medical routing.
Registered and regulated over unknown. Unregistered, imported, online or relative-supplied preparations of unknown origin carry the highest risk [source: Better Health Channel; Saper et al. 2008]. Practical meaning: help the client find out what a product is and who made it.
No delay of effective care. Ayurvedic treatment should not displace urgent treatment for psychosis, suicidality, mania, severe depression or seizures [synthesis].
Touch rules apply to referrals. Massage, marma and panchakarma involve close physical contact and intimate procedures. Practical meaning: the client should know they can refuse, give consent before and during, and stop at any time; no sexual or genital touch is ever legitimate [synthesis].
Cultural humility. Avoid both romanticising Ayurveda as "natural and safe" and dismissing it as superstition; both damage the alliance and safety [synthesis].
Consent and confidentiality in collaboration. Contact with practitioners only with explicit, specific consent [synthesis].

4. Intervention inventory

All interventions below are the psychotherapist's own. None is an Ayurvedic therapy. Where Ayurvedic practices are named, it is so the therapist can recognise and talk about them, not perform them [synthesis].

4.1 Cultural humility and self-examination

Purpose / when: Before and throughout work with clients who use Ayurveda; when you notice either enthusiasm ("natural, ancient, gentle") or contempt in yourself [synthesis].
Steps: (1) Note your own assumptions about Ayurveda, Indian and diaspora cultures, and "natural" remedies. (2) Separate the system (a regulated profession in India with statutory registers) from individual products, some of which are contaminated or unlicensed [source: BIMSTEC 2023 p.47; Saper et al. 2008]. (3) Seek supervision or consultation with a culturally knowledgeable colleague when unsure. (4) Revisit after any rupture involving Ayurveda [synthesis].
Example language (illustrative, to supervisor): "I notice I tensed up when she said her vaidya had prescribed a metal-based tablet. I want to stay curious and still make sure it's safe."
Watch for: Unexamined dismissal (client stops disclosing) or idealisation (missed toxicity). Working if you can ask safety questions without the client feeling judged [synthesis].

4.2 Cultural Formulation Interview (core and supplementary modules)

Purpose / when: At intake for any client whose cultural background, family or self-care involves Ayurveda, or who frames distress in Ayurvedic terms. The DSM-5-TR CFI covers the cultural definition of the problem, cultural perceptions of cause, context and support, cultural factors affecting self-coping and past help seeking, and cultural factors affecting current help seeking [source: https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/DSM-5-TR/APA-DSM5TR-CulturalFormulationInterview.pdf]; supplementary modules include explanatory model, coping and help-seeking, spirituality/religion/moral traditions, cultural identity, and immigrants and refugees [source: https://psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM5_Cultural-Formulation-Interview-Supplementary-Modules.pdf; use the APA's published version and do not reproduce items].
Steps: (1) Explain you ask everyone about their own understanding of their difficulties. (2) Work through the core domains in your own words. (3) Add the help-seeking module to map Ayurvedic, biomedical, religious and family sources of help. (4) Add the spirituality module where daivavyapashraya-type practices (mantras, amulets, gems, rites) matter to the client [source for those practices: KLE hospital article]. (5) Record the client's own terms verbatim (e.g. "too much vata", "weak agni") [synthesis].
Example language (illustrative): "People make sense of what they're going through in different ways. How would you, or your family, describe what's been happening to you?"; "Who else have you gone to for help—a doctor, an Ayurvedic practitioner, a temple, family?"
Watch for: Shortened, guarded answers suggest fear of disapproval; slow down and normalise. Working if the client volunteers Ayurvedic terms and practices you had not asked about [synthesis].

4.3 Eliciting the Ayurvedic explanatory model

Purpose / when: When the client attributes distress to dosha imbalance, digestion, diet, season, the mind's qualities, or divine causes. Kleinman's eight explanatory-model questions (Kleinman, Eisenberg and Good 1978) ask what the client calls the problem, what caused it, why it started when it did, what it does and how it works, how severe it is and whether it will last a short or long time, what treatment they should receive, what chief problems it has caused, and what they fear most about it [source: https://tanenbaum.org/wp-content/uploads/2021/06/HANDOUT-Explanatory-Models-of-Illness.pdf; https://www.cambridge.org/core/product/F99D9D36838A8207D377730DEB445F7B/core-reader].
Steps: (1) Ask what the condition is called in their framework and by their practitioner. (2) Ask about cause and course as they understand them. (3) Ask what the Ayurvedic practitioner has recommended and what the client hopes it will do. (4) Ask what they fear about psychiatric treatment. (5) Reflect the model back, attributed, and find shared goals (sleep, appetite, calm, routine) that both frameworks support [synthesis].
Example language (illustrative): "Your practitioner said this is an imbalance in vata that is unsettling your mind. What does that mean for how you think it should be treated?"; "Is there anything about counselling or medication that worries you, given how you see this?"
Watch for: A model that rules out any other help (risk of delay) versus one that can sit alongside psychotherapy. Working if the client can name goals shared across both systems [synthesis].

4.4 Non-judgemental inventory of Ayurvedic products and procedures

Purpose / when: At intake and at every medication or regimen review; regulators advise asking all patients about Ayurvedic and herbal products from any source [source: CDPH].
Steps: (1) Ask about every remedy taken by mouth, applied, or given to children, including tablets, powders, pellets, tonics, and items from practitioners, grocery stores, online sellers, travel abroad or relatives [source: CDPH; Better Health Channel]. (2) For each: name, purpose, who prescribed it, where bought, whether it is a rasa shastra (metal, mineral or gem containing) product, and whether it carries a regulatory code (e.g. AUST L/AUST R in Australia) [source: Better Health Channel]. (3) Ask about procedures: panchakarma (emesis, purgation, enemas, blood-letting, nasal therapies), massage, fasting, special diets [source: Better Health Channel; KLE hospital article]. (4) Ask the client to bring packaging or an ingredient list to their doctor; regulators advise asking practitioners for a full ingredient list [source: Better Health Channel; MHRA notice]. (5) Document and share with the medical team with consent [synthesis]. Do not comment on whether a product should be taken.
Example language (illustrative): "Many people use Ayurvedic medicines alongside other treatment. To keep you safe I ask everyone: what are you taking, who gave it to you, and where did it come from?"; "Could you take the packets or an ingredient list to your GP so they can look at them with you?"
Watch for: Products of unknown origin, unregistered imports, online purchases, items labelled as containing bhasma (preparations made from incinerated metals and minerals) [source: Journal of Ayurveda 2022 review, DOAJ record]. Working if the inventory is complete and the client's doctor has it [synthesis].

4.5 Toxic-metal red-flag screen and medical routing

Purpose / when: Whenever a client uses rasa shastra, imported, online or unregistered Ayurvedic products, or presents with unexplained physical symptoms. About one in five Ayurvedic medicines bought online in one US study contained detectable lead, mercury or arsenic; rasa shastra products were affected more often (40.6% vs 17.1%) and every metal-containing product exceeded at least one daily intake standard [source: Saper et al. 2008].
Steps: (1) Ask about symptoms regulators list: abdominal pain, nausea, vomiting, poor appetite, fatigue, anaemia; very high exposure can cause encephalopathy, seizures, coma and death; chronic exposure is linked to hypertension, kidney disease and cognitive dysfunction [source: CDPH; MMWR 2004]. (2) Remember that low-level exposure can be silent [source: CDPH]. (3) Note psychiatric overlap: fatigue, low mood, poor concentration and cognitive change can be misread as depression [synthesis]. (4) Urge prompt review by the client's physician, who can order a venous blood lead test, which regulators advise even without symptoms when exposure is possible [source: CDPH]. (5) If symptoms are severe or acute, direct to emergency care or poison control [source: CDPH; MHRA notice]. (6) Do not tell the client to stop or continue any product; the medical team manages exposure [synthesis, consistent with Better Health Channel].
Example language (illustrative): "Some Ayurvedic medicines, especially ones made with metals or bought online, have been found to contain lead or mercury. That doesn't mean yours does, but I'd like your doctor to check. Would you be willing to see them this week and take the medicines with you?"
Watch for: Abdominal pain, anaemia, new cognitive problems or seizures; several household members using the same product. Working if the physician is involved and the source is identified [synthesis; CDC: identifying the source and stopping exposure is primary management, MMWR 2004].

4.6 Pregnancy, fertility and child screen

Purpose / when: Any client who is pregnant, trying to conceive, breastfeeding, or caring for infants or children who receive remedies. Lead crosses the placenta and is associated with maternal hypertension, miscarriage, reduced fetal growth, preterm birth and neurodevelopmental effects; even low levels reduce IQ and cause learning and behaviour problems in children [source: CDPH]. CDC case reports include adults poisoned by Ayurvedic fertility remedies [source: MMWR 2004]; California reports infant poisoning linked to an imported infant tonic pill (Balguti Kesaria) subject to an FDA warning, and a pregnant woman with high blood and cord lead after a remedy for nausea [source: CDPH].
Steps: (1) Ask specifically about fertility, pregnancy-nausea, menstrual and infant-tonic remedies. (2) Ask who gives remedies to the children. (3) Route same-week to the obstetric, fertility or paediatric clinician with consent. (4) If a child is at risk and carers decline medical review, follow local safeguarding procedures [synthesis].
Example language (illustrative): "Because you're pregnant, I'm asking about anything you're taking for nausea or for the baby, including Ayurvedic or family remedies. Your midwife will want to know about all of them."
Watch for: Shame about fertility struggles that makes clients hide remedies; family pressure to give tonics to infants. Working if the obstetric or paediatric team has the full list [synthesis].

4.7 Physical-safety, consent and touch screen for panchakarma, massage and marma

Purpose / when: When a client is having or planning panchakarma, abhyanga, marma or residential cleansing programmes. Better Health warns panchakarma may be harmful in inexperienced hands and advises checking qualifications and experience [source: Better Health Channel]. Panchakarma includes emesis, enemas and blood-letting [source: Better Health Channel]. In a retrospective hospital series of 27 people given therapeutic purgation (virechana), 20 had abdominal cramping and 20 vomited [source: Chaganti and Prasad 2015].
Steps: (1) Ask whether a medical doctor knows about the planned procedures, especially with heart, kidney, diabetes, pregnancy or eating-disorder history [synthesis]. (2) Flag that induced vomiting, purgation and fasting can mimic or reinforce purging and restriction in eating disorders [synthesis]. (3) Ask about dehydration-type symptoms after procedures (dizziness, fainting, palpitations, confusion) and route to medical care [synthesis]. (4) Discuss consent: the client can ask what will happen before each procedure, consent before and during, refuse any part, and stop at any time; sexual or genital touch is never part of legitimate practice; intimate procedures (e.g. enemas) need explicit informed consent [synthesis]. (5) Ask whether the practitioner is registered where that is possible (e.g. the NCISM National or State Register in India) [source: BIMSTEC 2023 p.47]. The therapist gives no techniques, durations or temperatures.
Example language (illustrative): "Some of these cleansing treatments involve vomiting, enemas or massage. You have the right to know exactly what's planned, to say no to any part, and to stop at any time. Does your doctor know you're doing this?"
Watch for: Trauma survivors who freeze rather than refuse; clients in eating-disorder recovery drawn to purgation; any report of sexualised touch (see 4.13). Working if the client can describe how they would stop a procedure and their doctor is informed [synthesis].

4.8 Distinguishing culturally framed distress from disorders needing urgent treatment

Purpose / when: When a client or family frames psychosis, mania, severe depression, suicidality or seizures in Ayurvedic or divine terms (e.g. as a mind disorder for Ayurvedic or spiritual therapy), or when a family prefers Ayurvedic treatment to psychiatric care [synthesis; Ayurvedic categories attributed, KLE hospital article].
Steps: (1) Hold the client's framing respectfully while doing a standard risk and mental-state assessment. (2) Separate the meaning (how the family understands the illness) from the need (current risk, function, physical health). (3) Consider toxic-metal exposure as a contributor to cognitive change, confusion or seizures (see 4.5) [source for neurological effects: CDPH]. (4) Where urgent treatment is needed, present it as compatible with the family's framework where honest to do so, and involve a cultural broker if helpful. (5) Use standard suicide risk assessment and safety planning; lethal-means counselling covers storage and removal only [synthesis].
Example language (illustrative): "I understand your family sees this as an imbalance that Ayurveda can treat. Right now I'm worried about his safety and sleep, and the psychiatrist can help with that quickly. Many families use both."
Watch for: Weeks of untreated psychosis or mania while awaiting an Ayurvedic course; restriction or fasting regimens in a depressed or underweight client. Working if urgent treatment begins without the family feeling their framework was rejected [synthesis].

4.9 Collaboration and referral with registered Ayurvedic practitioners

Purpose / when: When the client wants their Ayurvedic and psychological care coordinated, or asks for a referral.
Steps: (1) Obtain specific written consent naming the practitioner and the information to be shared. (2) Help the client check registration where a register exists: in India, entry on the State and National Registers under the NCISM Act [source: BIMSTEC 2023 p.47]; in Australia, products should be on the ARTG with AUST L/R codes [source: Better Health Channel]; in the US, only voluntary NAMA certification exists [source: NAMA 2017]; in the UK, statutory registration is [uncertain]. (3) Share the psychological formulation in plain language and ask the practitioner to tell the prescriber about every product. (4) Ask the practitioner to share full ingredient lists with the medical team [source for ingredient lists: Better Health Channel]. (5) Agree who monitors what; the therapist monitors mood, risk and functioning, never products [synthesis].
Example language (illustrative, letter): "With [client]'s consent I am writing to coordinate care. I am seeing her for anxiety and low mood. She has asked that her GP have a complete ingredient list of the remedies you have prescribed. Please let me know if you would like to discuss her progress."
Watch for: Practitioner advice to stop psychiatric medicine; claims to cure severe mental illness; refusal to give ingredients. Working if the prescriber, practitioner and therapist share one current product list [synthesis].

4.10 Medication-adherence conversations without advising on medicines

Purpose / when: When a client says they have stopped, or plan to stop, prescribed psychiatric or medical treatment in favour of Ayurveda, or asks the therapist which to choose. Consumer guidance is never to stop conventional medicine or change its dose without the doctor's knowledge and approval [source: Better Health Channel].
Steps: (1) Explore the reasons (side effects, stigma, cost, family pressure, explanatory model) without arguing. (2) State your role clearly: you cannot advise on medicines. (3) Encourage a prompt conversation with the prescriber, and offer to help the client prepare questions. (4) With consent, inform the prescriber. (5) Assess risk if a stopped medicine was protecting against relapse [synthesis].
Example language (illustrative): "I can't tell you whether to take or stop any medicine, Ayurvedic or otherwise. What I can do is help you get your questions to your doctor this week. What would you most want to ask?"
Watch for: Abrupt discontinuation, withdrawal symptoms, early relapse signs. Working if the decision is made with the prescriber [synthesis].

4.11 Integrating Ayurvedic self-care the client values

Purpose / when: When daily and seasonal routines, diet, yoga, meditation or breathing practices, which Ayurvedic sources include among lifestyle measures [source: KLE hospital article; Better Health Channel], are meaningful and safe for the client.
Steps: (1) Ask which routines help and which feel burdensome. (2) Link helpful routines to treatment goals (sleep regularity, activity scheduling, relaxation). (3) Do not teach or prescribe Ayurvedic routines yourself; the content comes from the client and their practitioner. (4) Screen routines for risk (fasting, purgation, restrictive eating) and route these to medical care (see 4.7). (5) Note that sattvavajaya is described by Ayurvedic scholars as a psychological therapy that redirects the mind from unwholesome objects [source: Belaguli & Savitha 2019]; conceptual overlap with cognitive and behavioural work can be named if the client finds it helpful, without claiming to deliver sattvavajaya [synthesis].
Example language (illustrative): "You said your morning routine and the breathing practice your practitioner taught you make you feel steadier. Shall we build our sleep plan around those?"
Watch for: Routines becoming rigid or perfectionistic, or diet rules overlapping with disordered eating. Working if routines support, rather than replace, agreed goals [synthesis].

4.12 Families, diaspora context, interpreters and cultural brokers

Purpose / when: When products or regimens come through relatives, when language barriers exist, or when racism or past dismissal by services shapes mistrust. Consumer guidance warns against taking preparations from friends or relatives whose origin or ingredients cannot be identified [source: Better Health Channel]; regulators call for culturally appropriate education for communities who commonly use such remedies [source: MMWR 2004].
Steps: (1) Use a professional interpreter, not a family member, for safety questions. (2) Invite family members who supply remedies to a session with the client's consent. (3) Acknowledge experiences of dismissal by services. (4) Involve a cultural broker or community health worker where available. (5) Frame safety as protecting the family, especially children and pregnancies [synthesis].
Example language (illustrative): "Your mother brought these from India because she cares for you. Could we ask her to come in so we can all make sure they're safe for you and the baby?"
Watch for: Intergenerational conflict over remedies; the client being caught between family loyalty and medical advice. Working if the family joins the safety plan [synthesis].

4.13 Safeguarding and reporting

Purpose / when: When a product may be contaminated, when a child is exposed, when a practice causes injury, or when a client reports sexual or non-consensual touch during treatment.
Steps: (1) Contaminated or suspect products: encourage the client's doctor to report; in the UK suspected side effects can be reported via the Yellow Card scheme [source: MHRA notice]; in California adulterated products go to the CDPH Food and Drug Branch and urgent concerns to poison control [source: CDPH]. (2) Child exposure where carers decline medical review: follow local child-safeguarding procedures [synthesis]. (3) Sexual or non-consensual touch: support the client, document, explain options to report to police and to the practitioner's regulator or professional body where one exists, and follow mandatory reporting law [synthesis]. (4) Keep records factual and attributed [synthesis].
Example language (illustrative): "What you describe during the massage was not part of any legitimate treatment, and it's not your fault. Would you like to talk through the options for reporting it?"
Watch for: Self-blame, fear of community repercussions. Working if the client is safe and has made an informed choice about reporting [synthesis].

4.14 Integrating experiences of harm or benefit

Purpose / when: After poisoning, a distressing procedure, a delayed diagnosis, or conversely a meaningful experience of Ayurvedic care.
Steps: (1) Let the client tell the story in their own framework. (2) Separate the tradition (often part of identity and family) from the specific harm (a product, a practitioner, a delay). (3) Work with guilt, especially where a remedy affected a pregnancy or child. (4) Use the standard evidence-based trauma or grief treatment where indicated [synthesis].
Example language (illustrative): "It sounds like you can still value what Ayurveda means to your family, and be angry about what that particular medicine did. Both can be true."
Watch for: Shame preventing disclosure to other clinicians; total rejection of heritage that leaves the client isolated. Working if the client can hold both [synthesis].

5. Handling problems

Most guidance below is [synthesis]; regulator sources are cited where they apply.

Client will not disclose remedies. Normalise ("many people use both"), explain the question is asked of everyone [source: CDPH], separate safety from approval, and return to it later. If risk flags exist (pregnancy, children, symptoms), say plainly why it matters now.
Client or family insists the product is safe because it is natural, traditional or "purified". Do not debate the tradition. Note that practitioners claim processing reduces toxicity but surveys have not supported this [source: The Conversation], that herbal medicines can be as potent as drugs [source: Better Health Channel], and that only testing can tell; route to the doctor.
Client asks the therapist to choose between Ayurveda and psychiatric medicine. Decline the role, explore the dilemma, and route to the prescriber (4.10). Never advise starting, stopping or changing any medicine.
Rupture after a safety question (client feels their culture was judged). Acknowledge the impact, restate respect for their framework, and explain the specific concern (a product, not the system). Repair before returning to risk.
Stuck: client waits for an Ayurvedic course to work while symptoms worsen. Agree a time-limited review point with measurable markers (sleep, function, risk) and a plan for adding psychiatric care if markers are not met; involve family and a cultural broker.
Non-adherence to medical follow-up (e.g. blood lead testing). Problem-solve barriers (cost, transport, fear of blame, immigration fears) and, with consent, liaise with the GP. Persistent child exposure is a safeguarding matter (4.13).
Overwhelm after learning a remedy was contaminated. Contain, focus on next steps (medical review, identifying the source), address guilt, particularly about pregnancy or children (4.14).
Eating-disorder overlap with cleansing, fasting or purgation. Treat purgation-based regimens as a medical risk for clients with eating-disorder history; involve the eating-disorder team; avoid engaging in diet debates (4.7). No calorie or weight targets are given.
Disclosure of sexualised or non-consensual touch during massage or procedures. Believe, support, document, explain reporting options (4.13).
Client in pregnancy or trying to conceive using remedies. Same-week routing to the obstetric or fertility team (4.6) [source for risk: MMWR 2004; CDPH].
Practitioner advises stopping psychiatric treatment. With consent, contact the prescriber; do not mediate clinical decisions yourself.
Therapist pressure to "approve" a product or practitioner. You can help the client check registration (4.9) but cannot vouch for a product's safety.
Language and interpreter problems. Use professional interpreters for risk discussions; do not rely on the relative who supplies remedies (4.12).
Problems not addressed in the sources: spiritual or divine-therapy framing of a client's suicidality, family shame over a poisoning, and distrust of services after past dismissal. Handle with the CFI spirituality and help-seeking modules, cultural brokers and standard risk practice [synthesis].

Harm account

What was actually done

Rasa shastra and contaminated products. Rasa shastra medicines deliberately combine herbs with metals, minerals or gems [source: Saper et al. 2008; Better Health Channel; CDPH]. Other Ayurvedic products are contaminated with heavy metals [source: CDPH]. In 2005 researchers bought 230 randomly selected Ayurvedic oral medicines from 25 websites and tested 193 by x-ray fluorescence: 20.7% contained detectable lead, mercury or arsenic; US-made (21.7%) and Indian-made (19.5%) products were similar; rasa shastra products were affected more often (40.6% vs 17.1%) with higher median lead and mercury; 95% of metal-containing products were sold by US websites and 75% claimed Good Manufacturing Practices; all exceeded at least one acceptable daily intake standard [source: Saper et al. 2008, JAMA 300(8):915–923]. An earlier study of 70 South Asian-made Ayurvedic products bought in Boston-area stores in 2003 found lead, mercury or arsenic in 14 (20%), each of which could exceed US intake standards if taken as recommended [source: Saper et al. 2004, JAMA 292(23):2868–2873].
Case series, US 2000–2003. CDC described 12 adults in five states (New Hampshire, California, Massachusetts, New York, Texas) poisoned by Ayurvedic medications: a 37-year-old woman with rheumatoid arthritis took powders and tablets from an Ayurvedic physician in India, was treated with chelation, and was poisoned again two years later after restarting them; a 31-year-old woman took nine Ayurvedic fertility remedies, had severe anaemia after a miscarriage and very high blood lead, and one pill contained about 7% lead by weight; a 34-year-old man took fertility tablets and was hospitalised for chelation. The other nine took remedies for arthritis, menstrual health and diabetes [source: MMWR 2004;53(26)].
California cases. An imported tonic pill marketed for babies (Balguti Kesaria) has been linked to infant lead poisoning and is subject to an FDA warning; a pregnant woman taking a remedy for nausea had high blood and cord-blood lead; three fertility remedies delivered roughly 5,200 times the recommended adult maximum daily lead; a patient who took a stomach remedy for a year had anaemia and high blood lead [source: CDPH].
UK and Europe. In August 2013 the MHRA relayed Swedish National Food Agency findings of extremely high arsenic in products including Divya Kaishore Guggul and Chandraprabha Vati, marketed for conditions including infants' fevers, sore throats and skin infections, and stated it had received several reports of mercury, lead and arsenic in unlicensed Ayurvedic products [source: MHRA notice via Bromley Council].
Australia. Victoria has reported lead poisoning linked to Ayurvedic treatments imported from India, and some unregistered products sold in Victoria contain ingredients classed as poisons [source: Better Health Channel]; Sydney authorities seized suspect products from grocery stores after a woman using them was found to have high lead [source: The Conversation; reported as unconfirmed at the time].
Panchakarma. Panchakarma includes induced vomiting, enemas and blood-letting; it may be harmful when performed by inexperienced practitioners [source: Better Health Channel].
Delay of effective treatment. Use of Ayurvedic treatment in place of effective care for serious illness is a recognised risk in principle [synthesis].

How it caused harm

Lead: no known safe level; chronic exposure linked to hypertension, kidney disease, cognitive dysfunction, adverse reproductive outcomes and cardiovascular death; higher exposure causes anaemia, abdominal pain, nausea, poor appetite and fatigue; very high levels cause encephalopathy, seizures, coma and death [source: CDPH]. Lead crosses the placenta; associated outcomes include miscarriage, reduced fetal growth, preterm birth and neurodevelopmental harm; children's IQ, learning and behaviour are affected even at low levels [source: CDPH].
Mercury and arsenic: possible effects include nausea, vomiting, abdominal pain, kidney damage and nervous-system effects; arsenic and lead can cause convulsions; severe cases may be life-threatening [source: MHRA notice].
Who was most at risk: fetuses and young children, especially through fertility and infant remedies [source: MMWR 2004; CDPH]; people re-exposed after treatment [source: MMWR 2004]; buyers of online, imported or unregistered products [source: Saper et al. 2008; Better Health Channel]; pregnant and breastfeeding women and children, for whom most complementary medicines are untested [source: Better Health Channel].
Psychological sequelae: guilt (particularly where a pregnancy or child was affected), loss of trust in practitioners or family, and cognitive or mood symptoms from toxicity misread as primary psychiatric illness [synthesis].

Recognising it today

Products described as containing metals, minerals, gems or ash; unbranded, compounded or unlabelled powders and pellets; products bought online, in grocery stores, abroad or given by relatives; no regulatory code (in Australia, no AUST L/R) [source: CDPH; Better Health Channel; The Conversation].
Claims that traditional processing or "purification" makes metals safe [source: The Conversation, reporting practitioners' claims].
A "GMP" claim is not proof of safety: 75% of metal-containing products in the 2008 study claimed it [source: Saper et al. 2008].
Fertility, pregnancy-nausea, menstrual and infant-tonic remedies [source: MMWR 2004; CDPH].
Unexplained anaemia, abdominal pain, fatigue, cognitive change or seizures in a remedy user [source: CDPH; MMWR 2004].
Red flags in a practitioner or programme: refusal to give a full ingredient list [source: Better Health Channel, which advises asking for one]; advice to stop conventional treatment [contrary to Better Health Channel advice]; claims to cure severe mental illness or physical disease; intensive cleansing without medical screening; no verifiable registration where a register exists; pressure to continue procedures after the client wants to stop; any sexualised touch [synthesis].
How legitimate practice differs: registered practitioners, products with regulatory codes and full ingredient lists, coordination with the client's doctor, no discontinuation of conventional medicine without the doctor [source: Better Health Channel; BIMSTEC 2023 p.47; synthesis].

What to do instead and how to help those harmed

Safer alternatives (for the client to discuss with their own clinicians): products that are registered or listed with the national regulator; registered practitioners; evidence-based psychological and psychiatric treatment alongside any traditional care [source: Better Health Channel; synthesis].
Assessment of affected clients: full remedy inventory (4.4); prompt physician review and venous blood lead testing, including for household members [source: CDPH; MMWR 2004 tested children and spouse]; screening for cognitive and mood effects; trauma, grief and guilt assessment [synthesis].
Treatment: medical management of exposure rests with physicians (CDC: identify the source and stop exposure; chelation is reserved for marked symptoms or very high levels) [source: MMWR 2004]; the therapist supports engagement, addresses guilt and family conflict, and uses standard evidence-based treatment for resulting depression, anxiety or trauma [synthesis].
Ethical, reporting and legal duties: encourage reporting of suspect products to the relevant regulator (e.g. Yellow Card in the UK; CDPH Food and Drug Branch in California); urgent concerns to poison control [source: MHRA notice; CDPH]; follow child-safeguarding procedures where children remain exposed; follow mandatory reporting law for sexual misconduct; keep within role and never advise on medicines [synthesis].

Sources

American Psychiatric Association, DSM-5-TR Cultural Formulation Interview [source: https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/DSM-5-TR/APA-DSM5TR-CulturalFormulationInterview.pdf] and Supplementary Modules [source: https://psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM5_Cultural-Formulation-Interview-Supplementary-Modules.pdf]; Kleinman A, Eisenberg L, Good B (1978), Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research, Annals of Internal Medicine 88:251–258 [source: https://www.cambridge.org/core/product/F99D9D36838A8207D377730DEB445F7B/core-reader]. No cited source covers the UK statutory status of Ayurvedic practitioners or regulation in Nepal and Sri Lanka [uncertain].

← Previous · XI-006Okinawan yuta and noro Next · XI-008 →Siddha